OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...
Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
WIth one foot out the White House door, the Biden administration issued 2 documents Musk is now using in his battle to break ...
President Donald Trump spoke with OpenAI CEO Sam Altman by phone Friday, ahead of the AI infrastructure announcement, CNBC ...
Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in ...
Sam Altman's OpenAI is backing a new AI initiative from a group where John Kerry was a founding member that has voiced ...
OpenAI announced that it is launching a research preview of Operator, an AI agent that can take control of a browser and perform tasks.